In this episode of Analyzing Healthcare, brought to you by Scale Community, we sit down with Dr. William Briggs, CEO of Naitive, to explore the frontier of bone health innovation, with a sharp focus on osteoporosis diagnosis, musculoskeletal health, and healthcare technology. Dr. Briggs shares how Naitive is addressing critical gaps in orthopaedic care through a turnkey solution—“Bone Health Service in a Box”—powered by cutting-edge AI. From FDA approval of OsteoSight™ to piloting with leading orthopaedic groups, this conversation delivers actionable healthcare strategies, deep industry insights, and real-world applications for providers, payers, and innovators alike.

Title: Reinventing Musculoskeletal Care with AI – William Briggs, CEO at Naitive x Analyzing Healthcare

Key Timestamps:

• (00:00) Introduction to Naitive & the Future of Bone Health
• (04:27) The Silent Threat: Diagnosing Osteoporosis
• (06:03) Native’s Turnkey Solution for Orthopaedic Practices
• (10:52) Implementing Osteocyte: Integration & Usability
• (20:13) Go-to-Market Strategy & Commercial Potential
• (38:01) Vision Beyond Bones: Joint & Muscle Health Expansion

Key Takeaways:

• Naitive is building scalable solutions in musculoskeletal care, with a specific focus on osteoporosis—a condition that often goes undiagnosed.
• Their AI-powered platform, OsteoSight™, leverages routine imaging data to proactively detect bone loss.
• The company has received FDA Breakthrough Device Designation, reinforcing its potential clinical impact.
• Currently in pilot with leading orthopaedic groups, the implementation process is designed to be seamless and minimally disruptive.
• Dr. Briggs shares insights on whether Naitive will stay purely tech-focused or expand into human-led patient care services.
• The conversation covers market readiness, payer strategy, and what it takes to drive adoption among healthcare stakeholders.

About the Guest:

Dr. William Briggs is a Cambridge-trained physician and biochemist who transitioned from clinical practice in London to healthcare innovation. At Naitive, he developed OsteoSight™, an AI-powered tool that analyzes routine X-rays to detect early signs of osteoporosis, addressing the widespread underdiagnosis of this condition. Under his leadership, OsteoSight™ received FDA Breakthrough Device Designation, marking a significant advancement in proactive bone health management.

⁠linkedin.com/in/will-briggs-76585990⁠

⁠linkedin.com/in/jasonschifman ⁠

Keywords:

Bone Health, Osteoporosis, Naitive, Healthcare Innovation, Orthopaedics, Technology, Diagnosis, Patient Care, FDA Approval, Musculoskeletal Health, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman